Suzhou Fushilai Pharmaceutical (301258.SZ) Obtains European CEP Certificate for Active Pharmaceutical Ingredients

Suzhou Fushilai Pharmaceutical (301258.SZ) announced that the company has received the Certificate of Suitability (CEP) for the European Pharmacopoeia for the raw material drug Lipoic Acid issued by the European Directorate for Quality Medicines (EDQM). The manufacturer of Lipoic Acid is STADA in Germany, a compound belonging to the vitamin category, mainly used for diabetic polyneuropathy.